#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

In this “Ask Me Anything” (AMA) episode, Peter takes a deep dive into the liver and its central role in metabolic health. He explains why the liver can serve as a “canary in the coal mine” for metabolic dysfunction and explores how insulin resistance, visceral fat, alcohol consumption, genetics, and hormones contribute to liver disease, along with how increasing muscle mass can benefit liver health. Peter provides a framework for understanding the progression of liver disease, highlighting which stages are reversible and why early detection matters. He explains why normal liver enzymes can provide false reassurance, which labs he uses to assess liver health, and the tools available for detecting fibrosis and more advanced disease. Peter then breaks down the interventions that can meaningfully improve liver health once risk or disease is identified, ranging from diet and exercise to GLP-1–based therapies and other medications. Finally, he examines popular claims around liver “detoxification” and supplements, separating what is supported by evidence from what is unlikely to meaningfully improve liver health.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #88 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

• Why the liver is the “canary in the coal mine” for metabolic dysfunction, and an overview of what the liver does [2:00];
• The relationship between the liver and blood sugar control [6:30];
• A framework for understanding how metabolic disease affects the liver [9:15];
• Chronic caloric surplus and insulin resistance as drivers of liver disease [11:00];
• Liver diseases that result from metabolic dysfunction and the difference between steatosis and fibrosis [15:15];
• How visceral fat affects liver health [20:00];
• The importance of lifestyle interventions for liver and metabolic health: resistance training, not drinking calories, and the impact of fructose [22:00];
• Why alcohol-associated liver disease is more common than we give it credit for [26:30];
• Genetic and hormonal risks for liver disease [31:45];
• Labs that objectively measure liver health and the FIB-4 score [35:30];
• FibroScan: non-invasive imaging of the liver [44:30];
• The resiliency of the liver: an organ that can heal itself [47:00];
• Fibrosis staging and its impact on mortality and cancer risk [49:15];
• Interventions for someone with MASLD: weight loss and GLP-1s [52:00];
• Other medications used to treat metabolic liver disease [57:00];
• The role of exercise in treating metabolic liver disease: caloric deficit and building muscle [59:45];
• The myth of liver detoxes and cleanses, and a few supplements that may benefit the liver [1:01:15];
• A practical summary: how to assess your risk and the levers that reverse the disease [1:08:00]; and
• More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube